Lv1
40 积分 2023-02-14 加入
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT)
21天前
已完结
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
21天前
已完结
Semaglutide and NT-proBNP in Obesity-Related HFpEF
21天前
已完结
Correlation of CRP, fasting serum triglycerides and obesity as cardiovascular risk factors
28天前
已关闭
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
1个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
1个月前
已完结
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)
1个月前
已完结
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
2个月前
已完结
Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis
2个月前
已完结
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
2个月前
已完结
皖公网安备34019202002308
